Steven M. Paul

Biography

 Dr. Steven M. Paul, also known as Steve, M.D. has been the Chief Executive Officer of Voyager Therapeutics, Inc. since September 3, 2014 and has been its President since September 2014. Dr. Paul serves as a Venture Partner at Third Rock Ventures, LLC. He cofounded Tal Medical, Inc. in 2010 and serves as SAB Chair. He is the Founding Chief Executive Officer at Tal Medical. Dr. Paul is a world renowned psychiatrist, neuroscientist and drug developer. He has more than 20 years of management experience in the pharmaceutical and biotechnology industries and 37 years of scientific research experience. He has more than 35 years of neuroscience expertise. Dr. Paul joined Third Rock Ventures on October 5, 2010 and is a Senior Advisor to it and participates in the ideation and development of potential new companies. He is also the Professor of Neurology, Neuroscience, Psychiatry and Pharmacology at Weill Cornell Medical College of Cornell University. He serves as a Scientific Advisor at Excalibur Fund Managers Limited. He served as Advisor of PureTech Ventures. He founded Sage Therapeutics, Inc. in 2011 and served as its Interim Chief Scientific Officer and Founding Advisor. Dr. Paul served as Interim President of R&D of Voyager Therapeutics, Inc. from June 2013 to September 3, 2014. Dr. Paul spent 17 years at Eli Lilly, during which time he held several key leadership roles and was responsible for its overall research and development efforts - helping to expand Lilly's R&D efforts in oncology and biotechnology - resulting in a pipeline of approximately 70 new molecular entities. During Steve’s time at Lilly, Lilly launched some of the most successful psychiatric drugs of all time including the current market leading antidepressant, Cymbalta, which was developed under his direction. 

Research Interest

  Neurology, Neuroscience, Psychiatry and Pharmacology